Blackhawk's Life AI Corp Advances Its Asthma Attack Prediction Project
Blackhawk's Life AI Corp Advances Its Asthma Attack Prediction Project
VANCOUVER, BC / ACCESSWIRE / October 5, 2023 / Blackhawk Growth Corp. (CSE:BLR);(Frankfurt:0JJ) (the "Corporation" or "Blackhawk"), is pleased to report on the progress of its asthma attack prediction project, Asthmatic AI after visiting with scientific collaborators this past week.
不列顛哥倫比亞省溫哥華/ACCESSWIRE/2023年10月5日/黑鷹增長公司(CSE:BLR);(法蘭克福股票代碼:0JJ)(以下簡稱“公司”或“黑鷹”)在過去一週訪問了科學合作者後,很高興地報告了其哮喘發作預測專案哮喘人工智慧的進展情況。
Whilst the Company progresses with the pre-transaction requirements to complete the Hardenbrook Group acquisition, we are pleased to provide an update on Hardenbrook's portfolio company Asthmatic AI. Asthma is a long-term disease that causes inflammation and swelling of the airways. This results in the narrowing of the airways that carry air from the nose and mouth to the lungs. Asthma symptoms can be triggered by allergens like dust or pet dander, certain foods, environmental factors and exercise. Asthma can be deadly and there is no cure for it (in the US ten people die from asthma every day). According to the Asthma and Allergy Foundation of America, asthma is one of the most common and costly diseases in the United States. From 2008-2013 the average annual economic cost of asthma was more than $81.9 billion in the US including medical costs and loss of work and school days, with a significant burden to the health care cost of families dealing with asthma.
雖然公司正在推進完成對哈登布魯克集團收購的交易前要求,我們很高興提供哈登布魯克投資組合公司哮喘人工智慧的最新情況。哮喘是一種長期疾病,會導致呼吸道發炎和腫脹。這會導致將空氣從鼻子和口腔輸送到肺部的呼吸道變窄。哮喘癥狀可由塵埃或寵物皮屑等過敏原、某些食物、環境因素和鍛鍊引發。哮喘可能是致命的,而且沒有治癒方法(在美國,每天有10人死於哮喘)。根據美國哮喘和過敏基金會的數據,哮喘是美國最常見和最昂貴的疾病之一。從2008年到2013年,在美國,哮喘的年均經濟成本超過819億美元,其中包括醫療成本以及工作和上學天數的損失,這給患有哮喘的家庭帶來了巨大的醫療費用負擔。
Life AI Corp's scientific collaborators have started recruiting subjects and are collecting data to build machine-learning models and AI algorithms for reliable asthma attack prediction and prevention.
Life AI Corp的科學合作者已經開始招募受試者,並正在收集數據來構建機器學習模型和人工智慧算法,以可靠地預測和預防哮喘發作。
Life AI Corp is working on several new globally scalable health tech-focused AI companies that are conducting research at a leading research institution, collecting data and creating machine learning models for new product development in a variety of health domains.
Life AI Corp正在開發幾家新的全球可擴展的健康科技人工智慧公司,這些公司正在一家領先的研究機構進行研究,收集數據,並為各種健康領域的新產品開發創建機器學習模型。
Justin Hanka, Chief Executive Officer of Blackhawk Growth Corp said "We are pleased to see the progress of this exciting project unfold. Asthma is a debilitating condition which causes broad health, societal, emotional, and financial distress to families. We are excited by the hope that these asthma attack prediction models integrated to wearables will offer to individuals and families dealing with the condition".
Blackhawk Growth Corp首席執行官賈斯汀·漢卡表示:“我們很高興看到這個令人興奮的專案的進展。哮喘是一種衰弱的疾病,會給家庭帶來廣泛的健康、社會、情感和經濟方面的困擾。我們很高興這些集成到可穿戴設備中的哮喘發作預測模型將為應對這種疾病的個人和家庭提供幫助。”
Life AI Corp is conducting leading research in asthma attack prediction and prevention, early detection of autism and prediction of negative mood states such as depression and anxiety for early prevention and intervention. It is also developing a learning model for human performance optimization and longevity. With enough clinical data, Health AI models can be productized and integrated to digital devices such as smart watches and mobile devices to accurately support health monitoring, deliver health interventions and promote health optimization and longer living.
Life AI Corp正在哮喘發作的預測和預防、自閉症的早期檢測以及抑鬱和焦慮等負面情緒狀態的預測方面進行領先研究,以便及早預防和幹預。它還在開發一種用於人類性能優化和長壽的學習模型。有了足夠的臨床數據,Health AI模型可以被產品化並集成到智慧手錶和移動設備等數位設備上,以準確支持健康監測,提供健康幹預,促進健康優化和壽命延長。
Blackhawk is also pleased to announce that it has amended and restated investment agreement with Riverfort Global Opportunities PPC LTD ("RiverFort"). The outstanding amount has been fixed to CAD$2,207,500 with no additional interest or fees to accrue during an extended 36-month term. The outstanding balance has been reduced by $1,000,000 in consideration of Blackhawk novating the loan agreement with MindBio Therapeutics Corp to RiverFort. Interest is payable in the event of default of loan terms.
黑鷹還高興地宣佈,它已經修訂並重述了與Riverfort Global Opportunities PPC Ltd(“RiverFort”)的投資協定。未償還金額已固定為2,207,500加元,在延長的36個月期限內不會產生額外的利息或費用。由於黑鷹公司與MindBio治療公司簽署了向RiverFort提供貸款的協定,未償還餘額減少了100萬美元。如果拖欠貸款條款,則需要支付利息。
RiverFort may convert any portion of the loan at CAD $0.05. This restructure enables Blackhawk to release itself from any immediate short-term liabilities to RiverFort and reduces the dependency on repayment of the existing debt that was accrued and to be repaid by MindBio Therapeutics Corp following the successful spin-out earlier this year.
RiverFort可以0.05加元的價格轉換貸款的任何部分。這一重組使黑鷹能夠擺脫對RiverFort的任何直接短期債務,並減少對償還今年早些時候成功剝離後由MindBio治療公司償還的現有債務的依賴。
About Hardenbrook Group Hardenbrook Group, is an investment company that leverages a merchant banking model and works with world-class research-intensive organizations including large tier 1 universities to identify valuable intellectual property to invest, commercialize and take public on stock exchanges in North America. Its portfolio company Life AI Corp is conducting clinical health research and product development across several domains and is working toward a spin out and public listing in 2024.
哈登布魯克集團簡介哈登布魯克集團是一家投資公司,利用商業銀行模式,與包括大型一流大學在內的世界級研究密集型組織合作,確定有價值的知識產權,以便在北美的證券交易所投資、商業化和上市。其投資組合公司Life AI Corp正在多個領域進行臨床健康研究和產品開發,並致力於在2024年剝離並上市。
About Blackhawk Growth
Blackhawk is an investment holding company looking to create substantial value for its shareholders through the acquisition and development of high-growth companies.
關於黑鷹增長
黑鷹是一家投資控股公司,希望通過收購和發展高增長公司為其股東創造實質性價值。
To receive our latest updates, please register here:
要接收我們的最新更新,請在此處註冊:
For more information on Hardenbrook:
有關哈登布魯克的更多資訊,請訪問:
For more information on Life AI Corp:
有關Life AI Corp的更多資訊,請訪問:
Contact
Justin Hanka. Chief Executive Officer
61433140886
聯繫方式
賈斯汀·漢卡。首席執行官
61433140886
Cautionary Note Regarding Forward-Looking Statement
All statements in this press release, other than statements of historical fact, are "forward-looking information" with respect to the Company within the meaning of applicable securities laws. The Company provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. These risks and uncertainties include but are not limited those identified and reported in the Company's public filings under the Company's SEDAR profile at . Although the Company has attempted to identify important factors that could cause actual actions, event or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.
關於前瞻性陳述的注意事項
除歷史事實的陳述外,本新聞稿中的所有陳述均為適用證券法所指的有關該公司的“前瞻性資訊”。該公司提供前瞻性陳述的目的是傳達有關當前預期和未來計劃的資訊,請讀者注意,此類陳述可能不適合用於其他目的。就其性質而言,這類資訊具有固有的風險和不確定性,這些風險和不確定性可能是一般性的,也可能是具體的,導致預期、預測或結論可能被證明不準確,假設可能不正確,目標、戰略目標和優先事項將無法實現。這些風險和不確定性包括但不限於在公司的公開申報檔案中根據公司的SEDAR簡介確定和報告的風險和不確定性。儘管公司試圖找出可能導致實際行動、事件或結果與前瞻性資訊中描述的大不相同的重要因素,但可能還有其他因素導致行動、事件或結果與預期、估計或預期的不同。不能保證這些資訊將被證明是準確的,因為實際結果和未來事件可能與這類聲明中預期的大不相同。除非法律要求,否則公司不會因為新資訊、未來事件或其他原因而更新或修改任何前瞻性資訊,也不承擔任何義務。
SOURCE: Blackhawk Growth Corp.
資料來源:黑鷹增長公司